Crossmark

Peripheral Immune-Inflammatory Pathways in Major Depressive Disorder, Bipolar Disorder, and Schizophrenia: Exploring Their Potential as Treatment Targets

Crossref DOI link: https://doi.org/10.1007/s40263-025-01195-3

Published Online: 2025-06-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Almulla, Abbas F.

Maes, Michael https://orcid.org/0000-0002-2012-871X
License Information

Text and Data Mining valid from 2025-06-13

Version of Record valid from 2025-06-13
More Information

Article History

Accepted: 22 May 2025

First Online: 13 June 2025

Declarations

:

: Not applicable.

: Not applicable.

: Not applicable.

: The study was funded by FF66 grant and a Sompoch Endowment Fund (Faculty of Medicine), MDCU (RA66/016) to MM, and grant no. BG-RRP-2.004-0007-C01 Strategic Research and Innovation Program for the Development of MU–PLOVDIV–(SRIPD-MUP), Creation of a network of research higher schools, National plan for recovery and sustainability, European Union–NextGenerationEU.

: The authors confirm that there are no conflicts of interest associated with this manuscript.

: Not applicable.

: Not applicable.

: All authors contributed to drafting the paper. A.A. and M.M. designed the study and reviewed and approved the final draft.

Document is current

Any future updates will be listed below